REQUEST A DEMO
Total
USD $0.00
Search more companies

Sd Bio Sensor Inc. (South Korea)

Main Activities: Electromedical and Electrotherapeutic Apparatus Manufacturing
Full name: Sd Bio Sensor Inc. Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The company is a Korea-based company mainly engaged in the development and sale of in vitro diagnostics. The Company is engaged in the immunochemical diagnosis, molecular diagnosis, point-of-care diagnosis (POCTs), and self blood glucose measurement business. The Company is engaged in the research, development and sale of products such as rapid immunochemical diagnosis products, immunochemical fluorescence diagnosis products, molecular diagnosis products, enzyme immunological reaction diagnosis products and others. The Company distributes its products within domestic market and to overseas markets. The Company was founded on December 27, 2010. and its shares are listed on Korea Stock Exchange on July 16, 2021.

Headquarters
4-5F, C Dong, Digital Empire Bldg., 16, Deogyeong-Daero 1556Beon-Gil
Suwon; Gyeonggi;

Contact Details: Purchase the Sd Bio Sensor Inc. report to view the information.

Website: http://sdbiosensor.co.kr

Basic Information
Total Employees:
Purchase the Sd Bio Sensor Inc. report to view the information.
Outstanding Shares:
Purchase the Sd Bio Sensor Inc. report to view the information.
Registered Capital:
Purchase the Sd Bio Sensor Inc. report to view the information.
Financial Auditors:
Purchase the Sd Bio Sensor Inc. report to view the information.
Incorporation Date:
December 27, 2010
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Subsidiaries
㈜바이오노트
Company Performance
Financial values in the chart are available after Sd Bio Sensor Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
-0.34%
Total operating revenue
-0.82%
Operating profit (EBIT)
82.79%
EBITDA
N/A
Net Profit (Loss) for the Period
90.46%
Total assets
-4.59%
Total equity
7.71%
Operating Profit Margin (ROS)
49.96%
Net Profit Margin
80.05%
Return on Equity (ROE)
10.25%
Debt to Equity Ratio
-7.65%
Quick Ratio
3.06%
Cash Ratio
1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?